
London-founded Freshfields Bruckhaus Deringer is expanding yet again in the US, adding former Justice Department (DOJ) antitrust lawyer Julie Elmer as a partner in Washington, DC.
Elmer is the latest in a recent series of high-profile moves by the firm. Freshfields has been making good on growth plans in the US, which kicked into high gear last fall following the addition of a four-lawyer group from Cleary Gottlieb Steen & Hamilton that included mergers and acquisitions rainmaker Ethan Klingsberg.
Earlier this month, Freshfields opened an office in Silicon Valley, hiring five California lawyers in total from Big Law competitors Davis Polk & Wardwell, Latham & Watkins, Sidley Austin, and Wilson Sonsini Goodrich & Rosati. The firm also recently added former Willkie Farr & Gallagher business and corporate litigation practice group chair Mary Eaton in New York as the co-head of Freshfields’ new securities and shareholder litigation practice.
Elmer joined the DOJ’s antitrust division in 2015 as a trial attorney in its technology and financial services section. In 2017 she led the Division’s successful trial victory blocking Energy Solutions Inc.’s merger with Waste Control Specialists and more recently led the trial team in the DOJ’s challenge to Sabre’s acquisition of Farelogix. She played significant roles on trial teams in its cases involving AT&T, Time Warner, and United Continental Holdings.
Elmer, a former partner at Bradley Arant Boult Cummings, said she enjoyed her time in government, but missed the client relationships she developed in private practice. Freshfields, with its global footprint, commitment to expansion in the US, and familiar faces, was the best fit.
Full Content: Freshfields
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas